These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8633908)

  • 41. Advances in continuous renal replacement therapy: citrate anticoagulation update.
    Tolwani A; Wille KM
    Blood Purif; 2012; 34(2):88-93. PubMed ID: 23095407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Citrate kinetics in patients receiving long-term hemodialysis therapy.
    Bauer E; Derfler K; Joukhadar C; Druml W
    Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy.
    Saner FH; Treckmann JW; Geis A; Lösch C; Witzke O; Canbay A; Herget-Rosenthal S; Kribben A; Paul A; Feldkamp T
    Nephrol Dial Transplant; 2012 Apr; 27(4):1651-7. PubMed ID: 22049184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re: Regional citrate anticoagulation does not prolong filter survival during CVVH.
    Spronk PE; Steenbergen H; ten Kleij M; Rommes JH
    J Crit Care; 2006 Sep; 21(3):291-2; author reply 290-1. PubMed ID: 16990102
    [No Abstract]   [Full Text] [Related]  

  • 46. Issues with heparin, and the role of citrate.
    Kossmann RJ; Ahmad S
    Nephrol News Issues; 2008 Jun; 22(7):26-7. PubMed ID: 18795451
    [No Abstract]   [Full Text] [Related]  

  • 47. Trisodium citrate anticoagulation therapy.
    Michaud D
    Dynamics; 2001; 12(3):12. PubMed ID: 11982202
    [No Abstract]   [Full Text] [Related]  

  • 48. Citrate anticoagulation for hemodialysis patients at risk of bleeding.
    Collart FE; Tielemans CL; Wens R; Dratwa M
    Am J Nephrol; 1989; 9(3):263-4. PubMed ID: 2757082
    [No Abstract]   [Full Text] [Related]  

  • 49. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.
    Slowinski T; Morgera S; Joannidis M; Henneberg T; Stocker R; Helset E; Andersson K; Wehner M; Kozik-Jaromin J; Brett S; Hasslacher J; Stover JF; Peters H; Neumayer HH; Kindgen-Milles D
    Crit Care; 2015 Sep; 19():349. PubMed ID: 26415638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A target-orientated algorithm for regional citrate-calcium anticoagulation in extracorporeal therapies.
    Brandl M; Strobl K; Hartmann J; Kellner K; Posnicek T; Falkenhagen D
    Blood Purif; 2012; 33(1-3):7-20. PubMed ID: 22085810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulation for intermittent hemodialysis.
    Ouseph R; Ward RA
    Semin Dial; 2000; 13(3):181-7. PubMed ID: 10833779
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of sodium citrate and sodium citrate/ranitidine combination for acid aspiration prophylaxis.
    Chan YK
    Med J Malaysia; 1992 Mar; 47(1):27-30. PubMed ID: 1387445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
    Evenepoel P; Maes B; Vanwalleghem J; Kuypers D; Messiaen T; Vanrenterghem Y
    Am J Kidney Dis; 2002 Feb; 39(2):315-23. PubMed ID: 11840372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation.
    Calatzis A; Toepfer M; Schramm W; Spannagl M; Schiffl H
    Nephron; 2001 Oct; 89(2):233-6. PubMed ID: 11549910
    [No Abstract]   [Full Text] [Related]  

  • 55. Patient outcomes, economic benefits associated with a heparin change in hemodialysis, and nurses' satisfaction.
    Chevalier BA; Hudson S; Thompson K; Constantine C
    Nephrol Nurs J; 2011; 38(4):339-48. PubMed ID: 21928610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anticoagulation].
    Matsuda O
    Nihon Rinsho; 1991 Dec; 49 Suppl():279-86. PubMed ID: 1808269
    [No Abstract]   [Full Text] [Related]  

  • 57. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anticoagulants in hemodialysis therapy].
    Małyszko J; Małyszko JS; Myśliwiec M
    Przegl Lek; 1996; 53(5):454-8. PubMed ID: 8754412
    [No Abstract]   [Full Text] [Related]  

  • 59. Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
    Grudzinski L; Quinan P; Kwok S; Pierratos A
    Nephrol Dial Transplant; 2007 Feb; 22(2):471-6. PubMed ID: 17065193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
    Davies H; Morgan D; Leslie G
    Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.